Keywords: گلوکوکروبروزیداز; Gaucher disease; Genotype/phenotype correlation; Glucocerebrosidase; Sequencing;
مقالات ISI گلوکوکروبروزیداز (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: گلوکوکروبروزیداز; Alpha-synuclein; Red blood cells; Alpha-synuclein oligomers; Alpha-synuclein dimers; Glucocerebrosidase; Erythrocytes;
Keywords: گلوکوکروبروزیداز; Rapid eye movement sleep behavior disorder; RBD; Restless legs syndrome; RLS; Parkinson disease; Neurodegeneration; Genetics; Glucocerebrosidase; GBA;
Keywords: گلوکوکروبروزیداز; Parkinson disease; Complex I; Glucocerebrosidase; Dopamine metabolism; Monoamine oxidase; Dopamine (PubChem CID: 681); DOPAC (PubChem CID: 547); HVA (PubChem CID: 1738); 5-HIAA (PubChem CID: 1826); 3-OMD (PubChem CID: 38853);
Keywords: گلوکوکروبروزیداز; Glucocerebrosidase; Parkinson disease; Protein structure; Lysosome; Alpha-synuclein;
Keywords: گلوکوکروبروزیداز; GBA; Glucocerebrosidase; MD; Molecular Dynamics; GD; Gaucher Disease; PC; Pharmacological Chaperone; SP; Standard Precision; XP; Extra Precision; GBA; Gaucher disease; Molecular docking; Substructure search; Molecular dynamics; Blood brain barrier; Pharma
Keywords: گلوکوکروبروزیداز; Aβ; beta-amyloid peptide; AAV; adeno-associated virus; ABAD; amyloid-beta-binding alcohol dehydrogenase; AD; Alzheimer's disease; ALP; autophagy-lysosome pathways; Apaf-1; apoptic protease-activating factor 1; APP; amyloid precursor protein; AICD; APP in
Keywords: گلوکوکروبروزیداز; Glucocerebrosidase; GBA; Dementia; Aging; Parkinson's disease; Cognition;
Keywords: گلوکوکروبروزیداز; Lysosomal Storage Disorders; Oxidative stress; Reactive species; Oxidative damage; 4-HNE; 4-hydroxynonenal; 7-KC; 7-ketocholesterol; 8-OHdG; 8-hydroxy-2â²-deoxyguanosine; AGE; advanced glycation end product; BD; Batten disease; Ca2Â +; Â calcium; CAT; ca
Keywords: گلوکوکروبروزیداز; α-GlcChol; 1-O-cholesteryl-α-d-glucopyranoside; α-Syn; α-synuclein; β-GlcChol; 1-Î-cholesteryl-β-d-glucopyranoside or β-cholesterylglucoside; BMP; bis (monoacylglycero) phosphate; CERT; ceramide transfer protein; CNS; central nervous system; ER; e
Keywords: گلوکوکروبروزیداز; Tuberculosis; Gaucher disease; Glucocerebrosidase; Immune system
Keywords: گلوکوکروبروزیداز; Autophagy; Gaucher disease; Glucocerebrosidase; Lysosome; Mitochondria; mitophagy; Parkinson's disease;
Keywords: گلوکوکروبروزیداز; AAO; age at onset; CIs; confidence intervals; GBA; glucocerebrosidase; LRRK2; leucine-rich repeat kinase 2; MAPT; microtubule-associated protein tau; NOS; Newcastle-Ottawa Scale; ORs; odds ratios; PD; Parkinson's disease; SNCA; a-Synuclein; meta-analy
Keywords: گلوکوکروبروزیداز; ANOVA; one-way analysis of variance; BMD; bone mineral density; BMI; body mass index; CCL18; chemokine (C-C motif) ligand 18; EC; Enzyme commission number; ERT; enzyme replacement therapy; GBA; glucocerebrosidase; GD; Gaucher disease; DXA; dual energy X-r
Keywords: گلوکوکروبروزیداز; 6-OHDA; 6-hydroxydopamine; ADTIQ; 1-acetyl-6, 7-dihydroxyl-1, 2, 3, 4-tetrahydroisoquinoline; AMPK; 5â²-AMP-activated protein kinase; ATF; activating transcription factor 6; ATM; ataxia telangiectasia mutated; CHOP; CCAAT/-enhancer-binding protein homolo
Keywords: گلوکوکروبروزیداز; Parkinson disease; Glucocerebrosidase; Lysosome; Alpha-synuclein; Neuroprotection;
Keywords: گلوکوکروبروزیداز; Glucosylsphingosine; Mass spectrometry; Quantification; LC-MS/MS; Gaucher disease; Glucocerebrosidase
Keywords: گلوکوکروبروزیداز; α-Syn; alpha-synuclein; CBE; conduritol-B-epoxide; CCCP; carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone; CS; citrate synthase; Cx I; mitochondrial respiratory chain complex I; DA; dopaminergic; DIV; day in vitro; DMSO; dimethyl sulfoxide; EDTA; eth
Keywords: گلوکوکروبروزیداز; GBA; Glucocerebrosidase; Expression; Preeclampsia; Placenta; BMP4;
Keywords: گلوکوکروبروزیداز; Parkinson disease; Glucocerebrosidase; Parkinson's disease dementia
Keywords: گلوکوکروبروزیداز; Glucocerebrosidase; Beta-glucosidase; Early-onset Parkinson's disease; Familial Parkinson's disease;
Keywords: گلوکوکروبروزیداز; Alpha synuclein; Dopaminergic neurons; Glucocerebrosidase; Induced pluripotent stem cell; Leucine rich repeat kinase 2; Parkin; Parkinson's disease; PINK1α-SYN, alpha synuclein; CMA, chaperone mediated autophagy; DA, dopamine; DAT, dopamine active transpo
Keywords: گلوکوکروبروزیداز; lysosomal storage disorder; splenomegaly; glucocerebrosidase; enzyme replacement therapy; thrombocytopeniaLSD, lysosomal storage disorders; GD, Gaucher disease; GD1, Gaucher disease type 1; GD2, Gaucher disease type 2; GD3, Gaucher disease type 3; GBA, ac
Keywords: گلوکوکروبروزیداز; Parkinson disease; Parkinsonism; Diffuse Lewy body disease; Transcranial sonography; PET; Glucocerebrosidase; GBA; Gaucher disease; LRRK2;
Keywords: گلوکوکروبروزیداز; Parkinson's disease; Glucocerebrosidase; Autophagy; Mitochondria; Oxidative stress; Free radicals; Alpha-synuclein; Membrane potential; Neurodegeneration; Gaucher disease;
Keywords: گلوکوکروبروزیداز; ABCA12; ATP-binding cassette transporter A12; α-GalCer; α-galactosylceramide; AMPK; AMP-activated protein kinase; BMP; bis-monoacylglycero-phosphate; CBE; conduritol B epoxide; CerS; ceramide synthase; CERT; ceramide transport protein; ChlGlc; cholester
Keywords: گلوکوکروبروزیداز; Gaucher disease; Glucocerebrosidase; Optical coherence tomography; Parkinson's disease;
Keywords: گلوکوکروبروزیداز; SNc; substantia nigra pars compacta; PD; Parkinson disease; NMS; nonmotor symptoms; MAO-B; monoamine oxidase-B; MPP+; 1-methyl-4-phenylpyridinium; MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 6-OHDA; 6-hydroxy dopamine; GBA; glucocerebrosidase; STN
Keywords: گلوکوکروبروزیداز; LB; Lewy body; PD; Parkinson's disease; SN; substantia nigra; ROS; reactive oxygen species; IRE/IRP; iron responsive element/iron responsive protein; NBIA; neurodegeneration with brain iron accumulation; KRS; Kufor-Rakeb syndrome; LRRK2; leucine rich re
Keywords: گلوکوکروبروزیداز; Parkinson’s disease; Glucocerebrosidase; GBA; Genotype-phenotype correlation
Enzyme replacement therapy reverses B lymphocyte and dendritic cell dysregulations in patients with Gaucher Disease
Keywords: گلوکوکروبروزیداز; ACE; angiotensin conversion enzyme; CBC; complete blood count; CHITO; chitotriosidase; DC; dendritic cells; ERT; enzyme replacement therapy; GCase; Glucocerebrosidase; HC; healthy control; Hgb; hemoglobin; Ig; Immunoglobulin; MGUS; monoclonal gammopathy o
Novel hyperkinetic dystonia-like manifestation and neurological disease course of Swedish Gaucher patients
Keywords: گلوکوکروبروزیداز; Glucocerebrosidase; GBA1; Dystonia; Parkinson's disease; Gaucher disease;
UPR activation and CHOP mediated induction of GBA1 transcription in Gaucher disease
Keywords: گلوکوکروبروزیداز; Gaucher disease; glucocerebrosidase; UPR; CHOP;
The glycoprotein GPNMB is selectively elevated in the substantia nigra of Parkinson's disease patients and increases after lysosomal stress
Keywords: گلوکوکروبروزیداز; Parkinson's disease; Lysosome; GPNMB; Glucocerebrosidase; Lipidopathy; Post-mortem;
The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson's disease brain in association with the pathologic accumulation of alpha-synuclein
Keywords: گلوکوکروبروزیداز; 4-MUG; 4-methylumbelliferone α-d-galactopyranoside; GalNAc; N-acetyl-d-galactosamine; α-Gal A; alpha-Galactosidase A; α-syn; alpha-synuclein; ALP; autophagy-lysosome pathway; Cat B; cathepsin B; Cat D; cathepsin D; Gb3; globotriaosylceramide; lyso-Gb3;
Ambroxol modulates 6-Hydroxydopamine-induced temporal reduction in Glucocerebrosidase (GCase) enzymatic activity and Parkinson's disease symptoms
Keywords: گلوکوکروبروزیداز; Glucocerebrosidase; 6-Hydroxydopamine; Parkinson's disease; Ambroxol; α-synuclein; Mitochondrial dysfunction;
Novel and functional ATG12 gene variants in sporadic Parkinson's disease
Keywords: گلوکوکروبروزیداز; PD; Parkinson's disease; ATG; autophagy-related gene; DSVs; DNA sequence variants; SNCA; alpha synuclein gene; LRRK2; leucine-rich repeat kinase 2; VPS35; vacuolar protein sorting 35; PINK1; PTEN-induced kinase 1; GBA; Glucocerebrosidase; CMA; chaperone-m
Research articleGenetic analysis of the ATG16L1 gene promoter in sporadic Parkinson's disease
Keywords: گلوکوکروبروزیداز; ATG; autophagy-related gene; CNTNAP3; contactin associated protein-like 3; CSNK2; casein kinase 2; DSVs; DNA sequence variants; EVA1A; eva-1 homolog A; FIP200; focal adhesion kinase family interacting protein of 200Â kD; GBA; glucocerebrosidase; LC3B; mic
Jak rozpoznawaÄ i leczyÄ chorobÄ Gauchera: zarys patofizjologii, objawów klinicznych, metod diagnostycznych i leczenia
Keywords: گلوکوکروبروزیداز; glukocerebrozydaza; choroba Gauchera; badanie szpiku kostnego; komórka Gauchera; enzymatyczna terapia zastÄpcza; Glucocerebrosidase; Gaucher disease; Bone marrow examination; Gaucher cell; Enzyme replacement therapy;
Glucocerebrosidase haploinsufficiency in A53T α-synuclein mice impacts disease onset and course
Keywords: گلوکوکروبروزیداز; CAT; cathepsin; CBE; conduritol-β-epoxide; ER; endoplasmic reticulum; gba+/â;  heterozygous null mouse gba allele; GCase; glucocerebrosidase; GD; Gaucher disease; HMW; high molecular weight; LAMP2; lysosomal membrane protein 1; LIMP2; lysosomal integr
N-butyldeoxynojirimycin delays motor deficits, cerebellar microgliosis, and Purkinje cell loss in a mouse model of mucolipidosis type IV
Keywords: گلوکوکروبروزیداز; NB-DNJ; N-butyldeoxynojirimycin; GCS; glucosylceramide synthase; GSL; glycosphingolipid; CMH; ceramide monohexoside; CDH; ceramide dihexoside; GBA2; glucocerebrosidase; NPC; Niemann-Pick type C; SRT; substrate reduction therapy; Mucolipidosis type IV; Mig
The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal
Keywords: گلوکوکروبروزیداز; Parkinson's disease; Glucocerebrosidase; E326K; T369M; Synaptotagmin 11; GWAS;
LRRK2 deficiency impacts ceramide metabolism in brain
Keywords: گلوکوکروبروزیداز; Lipidomics; Sphingolipids; Parkinson's disease; Glucocerebrosidase; Gaucher's disease; Mass spectrometry;
Pilot study of newborn screening for six lysosomal storage diseases using Tandem Mass Spectrometry
Keywords: گلوکوکروبروزیداز; DBS; Dried blood spot on a newborn screening card; GAA; Acid α-glucosidase; GALC; Galactocerebrosidase; GBA; Glucocerebrosidase; GLA; α-Galactosidase A; IDUA; α-Iduronidase; MPS-I; Mucopolysaccharidosis-I; MS/MS; Tandem mass spectrometry; MRM; Multiple
Astrocytes and lysosomal storage diseases
Keywords: گلوکوکروبروزیداز; AD; Alzheimer's disease; DAMP; danger-associated molecular pattern; GBA; glucocerebrosidase; GFAP; glial fibrillary acidic protein; GLD; globoid cell leukodystrophy; INCL; infantile neuronal ceroid lipofuscinosis; JNCL; juvenile neuronal ceroid lipofusc
Advances in GBA-associated Parkinson's disease – Pathology, presentation and therapies
Keywords: گلوکوکروبروزیداز; Glucocerebrosidase; Gaucher disease; Parkinson's disease; α-Synuclein; LIMP-2
Neuropsychiatric characteristics of GBA-associated Parkinson disease
Keywords: گلوکوکروبروزیداز; Parkinson disease; Glucocerebrosidase; GBA1; Depression; Anxiety;
Presenting symptoms of GBA-related Parkinson's disease
Keywords: گلوکوکروبروزیداز; Pain; Glucocerebrosidase; Parkinson's disease; Presenting symptom;
Lack of enzyme activity in GBA2 mutants associated with hereditary spastic paraplegia/cerebellar ataxia (SPG46)
Keywords: گلوکوکروبروزیداز; Glucosylceramide; Spastic paraplegia; Cerebellar ataxia; Miglustat; GBA2; Enzyme activity; SPG46; Cer; ceramide; GBA; glucocerebrosidase; GBA2; β-glucosidase 2; Glc; glucose; GlcCer; glucosylceramide; NB-DGJ; N-butyldeoxygalactonojirimycin; NB-DNJ; N-but
Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells
Keywords: گلوکوکروبروزیداز; PD; Parkinson's disease; GD; Gaucher disease; GCase; glucocerebrosidase; Sap C; saposin C; PSAP; prosaposin; LIMP-2; lysosomal integral membrane 2; ER; endoplasmic reticulum; TFEB; transcription factor EB; GSK3; glycogen synthase kinase 3; UPS; ubiquitin